{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:01:21Z","timestamp":1787061681895,"version":"build-2736575974"},"reference-count":70,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2021.10702","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T02:41:22Z","timestamp":1630982482000},"source":"Crossref","is-referenced-by-count":3,"title":["Determination of whether HIPEC is beneficial in patients with synchronous peritoneal and liver metastases from colorectal cancer (Review)"],"prefix":"10.3892","volume":"22","author":[{"given":"Nicolae","family":"Bacalbasa","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Balescu","sequence":"additional","affiliation":[{"name":"Department of Visceral Surgery, \u2018Ponderas\u2019 Academic Hospital, 021188 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos","family":"Cretoiu","sequence":"additional","affiliation":[{"name":"Department of Cellular, Molecular and Histology Biology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Halmaciu","sequence":"additional","affiliation":[{"name":"Department of Anatomy, \u2018George Emil Palade\u2019 University of Medicine, Pharmacy, Science and Technology, 540142 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Dimitriu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Socea","sequence":"additional","affiliation":[{"name":"Department of Surgery, \u2018Sf. Pantelimon\u2019 Emergency Clinical Hospital, 021659 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Diaconu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Iliescu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornel","family":"Savu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Savu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, \u2018Fundeni\u2019 Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Filipescu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Stoica","sequence":"additional","affiliation":[{"name":"Department of Visceral Surgery, County Emergency Hospital Ilfov, 022104 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Stiru","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2021,9,7]]},"reference":[{"key":"key20211014132537_b1-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00384-014-1929-4","article-title":"Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases","volume":"29","author":"Sammartino","year":"2014","journal-title":"Int J Colorectal Dis"},{"key":"key20211014132537_b2-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"key":"key20211014132537_b3-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1200\/JOP.2016.011908","article-title":"Management of malignant peritoneal mesothelioma using cytoreductive surgery and perioperative chemotherapy","volume":"12","author":"Sugarbaker","year":"2016","journal-title":"J Oncol Pract"},{"key":"key20211014132537_b4-ETM-0-0-10702","author":"Sugarbaker"},{"key":"key20211014132537_b5-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13193-018-0856-1","article-title":"Prevention and treatment of peritoneal metastases: A comprehensive review","volume":"10","author":"Sugarbaker","year":"2019","journal-title":"Indian J Surg Oncol"},{"key":"key20211014132537_b6-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/BF02236627","article-title":"Treatment of primary colon cancer with peritoneal carcinomatosis: Comparison of concomitant vs delayed management","volume":"43","author":"Pestieau","year":"2000","journal-title":"Dis Colon Rectum"},{"issue":"529876","key":"key20211014132537_b7-ETM-0-0-10702","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/529876","article-title":"Adjuvant perioperative intraperitoneal chemotherapy in locally advanced colorectal carcinoma: Preliminary results","volume":"2011","author":"Tentes","year":"2011","journal-title":"ISRN Surg"},{"key":"key20211014132537_b8-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1245\/s10434-010-1319-2","article-title":"Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings","volume":"18","author":"Noura","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"key20211014132537_b9-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20211014132537_b10-ETM-0-0-10702","author":"Sugarbaker"},{"key":"key20211014132537_b11-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20211014132537_b12-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"key20211014132537_b13-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ejso.2006.03.013","article-title":"Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer","volume":"32","author":"Elias","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"key20211014132537_b14-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ctrv.2012.11.003","article-title":"Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies","volume":"39","author":"de Cuba","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"key20211014132537_b15-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12029-012-9452-8","article-title":"Surgical management of colorectal peritoneal metastases: Treatment and outcomes compared with hepatic metastases","volume":"44","author":"Tan","year":"2013","journal-title":"J Gastrointest Cancer"},{"key":"key20211014132537_b16-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/00015458.2015.11681109","article-title":"Simultaneous parenchyma-preserving liver resection, cytoreductive surgery and intraperitoneal chemotherapy for stage IV colorectal cancer","volume":"115","author":"Abreu de Carvalho","year":"2015","journal-title":"Acta Chir Belg"},{"key":"key20211014132537_b17-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"E167","DOI":"10.1111\/ans.13231","article-title":"Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: Results from an Australian centre","volume":"87","author":"Alzahrani","year":"2017","journal-title":"ANZ J Surg"},{"key":"key20211014132537_b18-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/DCR.0000000000001156","article-title":"Should a history of extraperitoneal disease be a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer peritoneal metastases?","volume":"61","author":"Baratti","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"key20211014132537_b19-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejso.2016.09.010","article-title":"Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer","volume":"43","author":"Lorimier","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"key20211014132537_b20-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"S666","DOI":"10.1245\/s10434-016-5543-2","article-title":"Surgical treatment of colorectal cancer with peritoneal and liver metastases using combined liver and cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Report from a single-centre experience","volume":"23 (Suppl 5)","author":"Navez","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"key20211014132537_b21-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijsu.2015.11.025","article-title":"Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?","volume":"25","author":"Delhorme","year":"2016","journal-title":"Int J Surg"},{"issue":"214","key":"key20211014132537_b22-ETM-0-0-10702","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-019-1746-x","article-title":"Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer","volume":"17","author":"Jeon","year":"2019","journal-title":"World J Surg Oncol"},{"key":"key20211014132537_b23-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00423-019-01787-w","article-title":"Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: Different strategies for curative treatment?","volume":"404","author":"Pinto","year":"2019","journal-title":"Langenbecks Arch Surg"},{"key":"key20211014132537_b24-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1007\/s12094-020-02346-2","article-title":"Hepatic resection and blood transfusion increase morbidity after cytoreductive surgery and HIPEC for colorectal carcinomatosis","volume":"22","author":"Soldevila-Verdeguer","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"LBA3503","key":"key20211014132537_b25-ETM-0-0-10702","article-title":"A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7","volume":"36 (Suppl 18)","author":"Quenet","year":"2018","journal-title":"J Clin Oncol"},{"key":"key20211014132537_b26-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.ejso.2020.04.018","article-title":"Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: A nationwide comparative study","volume":"46","author":"Bakkers","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"key20211014132537_b27-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3748\/wjg.14.1159","article-title":"Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis","volume":"14","author":"Al Shammaa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20211014132537_b28-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","article-title":"Peritoneal carcinomatosis from colorectal cancer","volume":"89","author":"Jayne","year":"2002","journal-title":"Br J Surg"},{"key":"key20211014132537_b29-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4240\/wjgs.v3.i12.183","article-title":"Current state of surgical treatment of liver metastases from colorectal cancer","volume":"3","author":"Grundmann","year":"2011","journal-title":"World J Gastrointest Surg"},{"key":"key20211014132537_b30-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","article-title":"Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer","volume":"203","author":"da Silva","year":"2006","journal-title":"J Am Coll Surg"},{"key":"key20211014132537_b31-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","article-title":"Extent of colorectal peritoneal carcinomatosis: Attempt to define a threshold above which HIPEC does not offer survival benefit: A comparative study","volume":"22","author":"Goere","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"key20211014132537_b32-ETM-0-0-10702","author":"Sugarbaker"},{"key":"key20211014132537_b33-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ejso.2019.11.515","article-title":"Delta peritoneal cancer index (\u0394PCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastases","volume":"46","author":"Hentzen","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"key20211014132537_b34-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","article-title":"Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin","volume":"40","author":"Elias","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"key20211014132537_b35-ETM-0-0-10702","first-page":"6877","article-title":"The role of re-resection for breast cancer liver metastases-a single center experience","volume":"35","author":"BacalbaSa","year":"2015","journal-title":"Anticancer Res"},{"key":"key20211014132537_b36-ETM-0-0-10702","first-page":"6919","article-title":"Long-term survivors after liver resection for ovarian cancer liver metastases","volume":"35","author":"BacalbaSa","year":"2015","journal-title":"Anticancer Res"},{"key":"key20211014132537_b37-ETM-0-0-10702","first-page":"6913","article-title":"Long-term survivors after liver resection for breast cancer liver metastases","volume":"35","author":"BacalbaSa","year":"2015","journal-title":"Anticancer Res"},{"key":"key20211014132537_b38-ETM-0-0-10702","first-page":"5563","article-title":"Role of surgical treatment in breast cancer liver metastases: A single center experience","volume":"34","author":"BacalbaSa","year":"2014","journal-title":"Anticancer Res"},{"issue":"235","key":"key20211014132537_b39-ETM-0-0-10702","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-015-0652-0","article-title":"Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit","volume":"13","author":"BacalbaSa","year":"2015","journal-title":"World J Surg Oncol"},{"key":"key20211014132537_b40-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"979","DOI":"10.21873\/invivo.11157","article-title":"Successful resection and vascular ligation of a large hepatic artery aneurysm-a case report and literature review","volume":"31","author":"Bacalbasa","year":"2017","journal-title":"In Vivo"},{"key":"key20211014132537_b41-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"983","DOI":"10.21873\/invivo.11158","article-title":"Management of a fulminant upper gastrointestinal bleeding exteriorized through hemobilia due to arteriobiliary fistula between the common bile duct and a right hepatic artery aneurysm-a case report","volume":"31","author":"BacalbaSa","year":"2017","journal-title":"In Vivo"},{"issue":"810","key":"key20211014132537_b42-ETM-0-0-10702","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-810","article-title":"Treatment of colorectal liver metastases in Germany: A ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma","volume":"14","author":"Hackl","year":"2014","journal-title":"BMC Cancer"},{"key":"key20211014132537_b43-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1200\/JCO.2008.19.9273","article-title":"Patients with initially unresectable colorectal liver metastases: Is there a possibility of cure?","volume":"27","author":"Adam","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20211014132537_b44-ETM-0-0-10702","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11888-010-0050-5","article-title":"Curative approach for stage IV colorectal cancer with multiorgan involvement: What makes sense and what doesn't?","volume":"6","author":"Khrizman","year":"2010","journal-title":"Curr Colorectal Cancer Rep"},{"key":"key20211014132537_b45-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement","volume":"14","author":"Esquivel","year":"2007","journal-title":"Society of surgical oncology. Ann Surg Oncol"},{"key":"key20211014132537_b46-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.ejso.2018.07.003","article-title":"The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the peritoneal surface oncology group international (PSOGI)","volume":"44","author":"Bushati","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"key20211014132537_b47-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clcc.2020.06.010","article-title":"Patient selection for hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer: Consensus on decision making among international experts","volume":"19","author":"Steffen","year":"2020","journal-title":"Clin Colorectal Cancer"},{"issue":"49","key":"key20211014132537_b48-ETM-0-0-10702","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-018-0563-8","article-title":"Metastatic colorectal cancer to the peritoneum: Current treatment options","volume":"19","author":"Vassos","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"key20211014132537_b49-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/SLA.0b013e3182778089","article-title":"Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study","volume":"258","author":"Maggiori","year":"2013","journal-title":"Ann Surg"},{"key":"key20211014132537_b50-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jss.2017.05.126","article-title":"Safety and efficacy of combined resection of colorectal peritoneal and liver metastases","volume":"219","author":"Downs-Canner","year":"2017","journal-title":"J Surg Res"},{"key":"key20211014132537_b51-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1245\/s10434-019-07452-2","article-title":"Prognostic impact of BRAF and KRAS mutation in patients with colorectal and appendiceal peritoneal metastases scheduled for CRS and HIPEC","volume":"27","author":"Graf","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"key20211014132537_b52-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jss.2019.02.050","article-title":"RAS mutation status confers prognostic relevance in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer","volume":"240","author":"Morgan","year":"2019","journal-title":"J Surg Res"},{"key":"key20211014132537_b53-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12094-019-02124-9","article-title":"Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): Multicenter study of the Spanish group of peritoneal cancer surgery (GECOP)","volume":"22","author":"Cascales-Campos","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"key20211014132537_b54-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1007\/s11605-018-3784-z","article-title":"Impact of synchronous liver resection on the perioperative outcomes of patients undergoing CRS-HIPEC","volume":"22","author":"Cloyd","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"key20211014132537_b55-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: Five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"key20211014132537_b56-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1245\/s10434-019-07935-2","article-title":"Colorectal peritoneal metastases treated by perioperative systemic chemotherapy and cytoreductive surgery with or without mitomycin C-Based HIPEC: A comparative study using the peritoneal surface disease severity score (PSDSS)","volume":"27","author":"Baratti","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"key20211014132537_b57-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00280-007-0654-x","article-title":"Pharmacokinetics of heated intraperitoneal oxaliplatin","volume":"62","author":"Ferron","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20211014132537_b58-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00228-008-0511-9","article-title":"Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion","volume":"64","author":"Mahteme","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"key20211014132537_b59-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20211014132537_b60-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/SLA.0b013e3182263933","article-title":"Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis","volume":"254","author":"Quenet","year":"2011","journal-title":"Ann Surg"},{"key":"key20211014132537_b61-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.critrevonc.2019.06.014","article-title":"Systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer","volume":"142","author":"Wisselink","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20211014132537_b62-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.ejso.2020.04.019","article-title":"Identification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases","volume":"46","author":"Hulshof","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"807","key":"key20211014132537_b63-ETM-0-0-10702","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-807","article-title":"Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: A retrospective analysis","volume":"14","author":"Glockzin","year":"2014","journal-title":"BMC Cancer"},{"key":"key20211014132537_b64-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"O264","DOI":"10.1111\/codi.12560","article-title":"A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer","volume":"16","author":"Hompes","year":"2014","journal-title":"Colorectal Dis"},{"key":"key20211014132537_b65-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/jso.21836","article-title":"Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy","volume":"103","author":"Klaver","year":"2011","journal-title":"J Surg Oncol"},{"key":"key20211014132537_b66-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1245\/s10434-016-5712-3","article-title":"The role of neoadjuvant and adjuvant systemic chemotherapy with cytoreductive surgery and heated intraperitoneal chemotherapy for colorectal peritoneal metastases: A systematic review","volume":"24","author":"Waite","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"key20211014132537_b67-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1200\/JCO.2005.00.232","article-title":"Combined analysis of efficacy: The addition of bevacizumab to fluorouracil\/leucovorin improves survival for patients with metastatic colorectal cancer","volume":"23","author":"Kabbinavar","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20211014132537_b68-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","article-title":"Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study","volume":"26","author":"Saltz","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20211014132537_b69-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1470-2045(09)70112-3","article-title":"Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: A meta-analysis","volume":"10","author":"Hapani","year":"2009","journal-title":"Lancet Oncol"},{"key":"key20211014132537_b70-ETM-0-0-10702","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1245\/s10434-013-3442-3","article-title":"Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin","volume":"21","author":"Eveno","year":"2014","journal-title":"Ann Surg Oncol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T09:12:20Z","timestamp":1634202740000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2021.10702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,7]]},"references-count":70,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,9,7]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2021.10702","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,7]]},"article-number":"1267"}}